What if you could use your own body’s natural resources to enhance your sexual response, strengthen orgasm, and improve sexual performance?
Stem Cell Sexual Optimization are regenerative therapies that offer women and men with sexual dysfunction, urinary incontinence, low libido and other sexual concerns the opportunity to improve functional potential using stem cell technology.
These therapies are based on the premise that: 1) sexual disfunction is largely a circulatory issue, and 2) a major mechanism of action of site-specific injection of stem cells is the growth of new, healthy vasculature and thereby a return to adequate circulation.
Stem Cell Sexual Optimization for Women – The O-Shot
SCSO for women is a simple office procedure that uses growth factors from platelet rich plasma with or without fat-derrived stem cells in the vagina and clitoral tissue. Injections are made after topical anesthetic cream has been applied to minimize discomfort and are surprisingly tolerable.
Each woman’s experience is different but many patients report the following:
• Stronger, more frequent orgasm
• Increased sexual desire and arousal
• Smoother skin and tighter vaginal opening
• Decreased pain during intercourse
• Increased lubrication
• Decreased urinary incontinence.
Stem Cell Sexual Optimization for Men – The P-Shot
SCSO for men is a non-surgical proprietary technique that uses the regenerative properties of PRP with or without fat-derrived stem cells to deliver lasting improvements in male sexual performance. Like SCSO for women, a topical numbing cream is applied before the procedure so discomfort is minimal.
Experiences vary but men commonly report the following benefits:
• Improved blood flow and firmness of erections
• Increased sensation and pleasure
• Enhanced appearance
• Improved sexual stamina and capabilities
• Improved urinary incontinence
• Improved prostate discomfort
HOW DO I LEARN MORE?
Albersen, M et al. Multipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunction. The Journal of Sexual Medicine, Vol 9, Issue 2, pages 385–403, Feb 2012
Bahk JY et al. Treatment of diabetic impotence with umbilical cord blood stem cells intracavernosal transplant: preliminary report of 7 cases. Exp Clin Transplant 2010;8:150-60
Casabona, F et al. New surgical approach to lichen sclerosus of the vulva: The role of adipose derived mesenchymal cells and platelet rich plasma in tissue regeneration. Plastic and Reconstructive Surgery, Oct 2010, Vol 126, Issue 4.
Ding XG. , et al. Effects of platelet rick plasma on the regeneration of the cavernous nerve: experiment with rats. Zhongua Yi Xue Za Zhi. 2008: 88(36): 2578-80.
Haar MK et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open label phase 1 clinical trial. EBioMedicine 2016;5:204-10
Levy JA et al. Determining the feasibility of managing erectile dysfunction in humans with placental-derived stem cells. J Am Osteopath Assoc 2016; 116:e1-5
Runels CE, et al. A Pilot Study of the Effect of Localized Injections of Autologous Platelet Rich Plasma (PRP) for the Treatment of Female Sexual Dysfunction. J Women’s Health Care 2014, 3:4
Virag, R, et al. A new treatment of Lapeyronie’s Disease by local injections of plasma rich platelets and hyaluronic acid. E-mémoires de l'Académie Nationale de Chirurgie, 2014, 13 (3) : 096-100.
Wu, CC et al. The neuroprotective effect of platelet-rich plasma on erectile dysfunction in bilateral cavernous nerve injury rat model. The Journal of Sexual Med, 2012 Nov; 9(11)
Yiou R et al. Safety of intracavernous bone marrow-mononuclear cells for postradical prostatectomy erectile dysfunction: an open dose-escalation pilot study. Eur Urol 2016; 69: 988-91.